Global Immunocell Therapy Market Growth (Status and Outlook) 2025-2031

September 2025 | 110 pages | ID: G2CA7137FE25EN
LP Information

Abstracts

According to this study, the global Immunocell Therapy market size will reach US$ 5528 million by 2031.

Immune therapy is a new class of cancer treatment designed to boost or enhance the body’s immune system to more efficiently target and destroy cancerous cells. Many experts believe that immunotherapy represents the most promising new cancer treatment since the development of chemotherapy.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Immunocell Therapy Industry Forecast” looks at past sales and reviews total world Immunocell Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Immunocell Therapy sales for 2025 through 2031. With Immunocell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immunocell Therapy industry.

This Insight Report provides a comprehensive analysis of the global Immunocell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Immunocell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immunocell Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immunocell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immunocell Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Immunocell Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Chimeric Antigen Receptor (CAR) T Cell Therapy
• Natural Killer (NK) Cell Therapy
• Others

Segmentation by Application:

• Hospitals
• Clinics
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novartis
• Gilead Sciences
• Bristol-Myers Squibb
• J & J
• JW Therapeutics
• FOSUNKite
• CARsgen Therapeutics (Pipeline)
• Autolus Therapeutics(Pipeline)
• Sorrento Therapeutics(Pipeline)
• Mustang Bio(Pipeline)
• Bluebird Bio(Pipeline)
• Cellectis(Pipeline)
• Allogene Therapeutics(Pipeline)
• Celyad(Pipeline)

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Immunocell Therapy Market Size (2020-2031)
  2.1.2 Immunocell Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Immunocell Therapy by Country/Region (2020, 2024 & 2031)
2.2 Immunocell Therapy Segment by Type
  2.2.1 Chimeric Antigen Receptor (CAR) T Cell Therapy
  2.2.2 Natural Killer (NK) Cell Therapy
  2.2.3 Others
2.3 Immunocell Therapy Market Size by Type
  2.3.1 Immunocell Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Immunocell Therapy Market Size Market Share by Type (2020-2025)
2.4 Immunocell Therapy Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Others
2.5 Immunocell Therapy Market Size by Application
  2.5.1 Immunocell Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Immunocell Therapy Market Size Market Share by Application (2020-2025)

3 IMMUNOCELL THERAPY MARKET SIZE BY PLAYER

3.1 Immunocell Therapy Market Size Market Share by Player
  3.1.1 Global Immunocell Therapy Revenue by Player (2020-2025)
  3.1.2 Global Immunocell Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Immunocell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 IMMUNOCELL THERAPY BY REGION

4.1 Immunocell Therapy Market Size by Region (2020-2025)
4.2 Global Immunocell Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Immunocell Therapy Market Size Growth (2020-2025)
4.4 APAC Immunocell Therapy Market Size Growth (2020-2025)
4.5 Europe Immunocell Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Immunocell Therapy Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Immunocell Therapy Market Size by Country (2020-2025)
5.2 Americas Immunocell Therapy Market Size by Type (2020-2025)
5.3 Americas Immunocell Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Immunocell Therapy Market Size by Region (2020-2025)
6.2 APAC Immunocell Therapy Market Size by Type (2020-2025)
6.3 APAC Immunocell Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Immunocell Therapy Market Size by Country (2020-2025)
7.2 Europe Immunocell Therapy Market Size by Type (2020-2025)
7.3 Europe Immunocell Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Immunocell Therapy by Region (2020-2025)
8.2 Middle East & Africa Immunocell Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Immunocell Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL IMMUNOCELL THERAPY MARKET FORECAST

10.1 Global Immunocell Therapy Forecast by Region (2026-2031)
  10.1.1 Global Immunocell Therapy Forecast by Region (2026-2031)
  10.1.2 Americas Immunocell Therapy Forecast
  10.1.3 APAC Immunocell Therapy Forecast
  10.1.4 Europe Immunocell Therapy Forecast
  10.1.5 Middle East & Africa Immunocell Therapy Forecast
10.2 Americas Immunocell Therapy Forecast by Country (2026-2031)
  10.2.1 United States Market Immunocell Therapy Forecast
  10.2.2 Canada Market Immunocell Therapy Forecast
  10.2.3 Mexico Market Immunocell Therapy Forecast
  10.2.4 Brazil Market Immunocell Therapy Forecast
10.3 APAC Immunocell Therapy Forecast by Region (2026-2031)
  10.3.1 China Immunocell Therapy Market Forecast
  10.3.2 Japan Market Immunocell Therapy Forecast
  10.3.3 Korea Market Immunocell Therapy Forecast
  10.3.4 Southeast Asia Market Immunocell Therapy Forecast
  10.3.5 India Market Immunocell Therapy Forecast
  10.3.6 Australia Market Immunocell Therapy Forecast
10.4 Europe Immunocell Therapy Forecast by Country (2026-2031)
  10.4.1 Germany Market Immunocell Therapy Forecast
  10.4.2 France Market Immunocell Therapy Forecast
  10.4.3 UK Market Immunocell Therapy Forecast
  10.4.4 Italy Market Immunocell Therapy Forecast
  10.4.5 Russia Market Immunocell Therapy Forecast
10.5 Middle East & Africa Immunocell Therapy Forecast by Region (2026-2031)
  10.5.1 Egypt Market Immunocell Therapy Forecast
  10.5.2 South Africa Market Immunocell Therapy Forecast
  10.5.3 Israel Market Immunocell Therapy Forecast
  10.5.4 Turkey Market Immunocell Therapy Forecast
10.6 Global Immunocell Therapy Forecast by Type (2026-2031)
10.7 Global Immunocell Therapy Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Immunocell Therapy Forecast

11 KEY PLAYERS ANALYSIS

11.1 Novartis
  11.1.1 Novartis Company Information
  11.1.2 Novartis Immunocell Therapy Product Offered
  11.1.3 Novartis Immunocell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Novartis Main Business Overview
  11.1.5 Novartis Latest Developments
11.2 Gilead Sciences
  11.2.1 Gilead Sciences Company Information
  11.2.2 Gilead Sciences Immunocell Therapy Product Offered
  11.2.3 Gilead Sciences Immunocell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Gilead Sciences Main Business Overview
  11.2.5 Gilead Sciences Latest Developments
11.3 Bristol-Myers Squibb
  11.3.1 Bristol-Myers Squibb Company Information
  11.3.2 Bristol-Myers Squibb Immunocell Therapy Product Offered
  11.3.3 Bristol-Myers Squibb Immunocell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Bristol-Myers Squibb Main Business Overview
  11.3.5 Bristol-Myers Squibb Latest Developments
11.4 J & J
  11.4.1 J & J Company Information
  11.4.2 J & J Immunocell Therapy Product Offered
  11.4.3 J & J Immunocell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 J & J Main Business Overview
  11.4.5 J & J Latest Developments
11.5 JW Therapeutics
  11.5.1 JW Therapeutics Company Information
  11.5.2 JW Therapeutics Immunocell Therapy Product Offered
  11.5.3 JW Therapeutics Immunocell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 JW Therapeutics Main Business Overview
  11.5.5 JW Therapeutics Latest Developments
11.6 FOSUNKite
  11.6.1 FOSUNKite Company Information
  11.6.2 FOSUNKite Immunocell Therapy Product Offered
  11.6.3 FOSUNKite Immunocell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 FOSUNKite Main Business Overview
  11.6.5 FOSUNKite Latest Developments
11.7 CARsgen Therapeutics (Pipeline)
  11.7.1 CARsgen Therapeutics (Pipeline) Company Information
  11.7.2 CARsgen Therapeutics (Pipeline) Immunocell Therapy Product Offered
  11.7.3 CARsgen Therapeutics (Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 CARsgen Therapeutics (Pipeline) Main Business Overview
  11.7.5 CARsgen Therapeutics (Pipeline) Latest Developments
11.8 Autolus Therapeutics(Pipeline)
  11.8.1 Autolus Therapeutics(Pipeline) Company Information
  11.8.2 Autolus Therapeutics(Pipeline) Immunocell Therapy Product Offered
  11.8.3 Autolus Therapeutics(Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Autolus Therapeutics(Pipeline) Main Business Overview
  11.8.5 Autolus Therapeutics(Pipeline) Latest Developments
11.9 Sorrento Therapeutics(Pipeline)
  11.9.1 Sorrento Therapeutics(Pipeline) Company Information
  11.9.2 Sorrento Therapeutics(Pipeline) Immunocell Therapy Product Offered
  11.9.3 Sorrento Therapeutics(Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Sorrento Therapeutics(Pipeline) Main Business Overview
  11.9.5 Sorrento Therapeutics(Pipeline) Latest Developments
11.10 Mustang Bio(Pipeline)
  11.10.1 Mustang Bio(Pipeline) Company Information
  11.10.2 Mustang Bio(Pipeline) Immunocell Therapy Product Offered
  11.10.3 Mustang Bio(Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Mustang Bio(Pipeline) Main Business Overview
  11.10.5 Mustang Bio(Pipeline) Latest Developments
11.11 Bluebird Bio(Pipeline)
  11.11.1 Bluebird Bio(Pipeline) Company Information
  11.11.2 Bluebird Bio(Pipeline) Immunocell Therapy Product Offered
  11.11.3 Bluebird Bio(Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Bluebird Bio(Pipeline) Main Business Overview
  11.11.5 Bluebird Bio(Pipeline) Latest Developments
11.12 Cellectis(Pipeline)
  11.12.1 Cellectis(Pipeline) Company Information
  11.12.2 Cellectis(Pipeline) Immunocell Therapy Product Offered
  11.12.3 Cellectis(Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Cellectis(Pipeline) Main Business Overview
  11.12.5 Cellectis(Pipeline) Latest Developments
11.13 Allogene Therapeutics(Pipeline)
  11.13.1 Allogene Therapeutics(Pipeline) Company Information
  11.13.2 Allogene Therapeutics(Pipeline) Immunocell Therapy Product Offered
  11.13.3 Allogene Therapeutics(Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Allogene Therapeutics(Pipeline) Main Business Overview
  11.13.5 Allogene Therapeutics(Pipeline) Latest Developments
11.14 Celyad(Pipeline)
  11.14.1 Celyad(Pipeline) Company Information
  11.14.2 Celyad(Pipeline) Immunocell Therapy Product Offered
  11.14.3 Celyad(Pipeline) Immunocell Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Celyad(Pipeline) Main Business Overview
  11.14.5 Celyad(Pipeline) Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Immunocell Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Immunocell Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Chimeric Antigen Receptor (CAR) T Cell Therapy
Table 4. Major Players of Natural Killer (NK) Cell Therapy
Table 5. Major Players of Others
Table 6. Immunocell Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Immunocell Therapy Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Immunocell Therapy Market Size Market Share by Type (2020-2025)
Table 9. Immunocell Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Immunocell Therapy Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Immunocell Therapy Market Size Market Share by Application (2020-2025)
Table 12. Global Immunocell Therapy Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Immunocell Therapy Revenue Market Share by Player (2020-2025)
Table 14. Immunocell Therapy Key Players Head office and Products Offered
Table 15. Immunocell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Immunocell Therapy Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Immunocell Therapy Market Size Market Share by Region (2020-2025)
Table 20. Global Immunocell Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Immunocell Therapy Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Immunocell Therapy Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Immunocell Therapy Market Size Market Share by Country (2020-2025)
Table 24. Americas Immunocell Therapy Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Immunocell Therapy Market Size Market Share by Type (2020-2025)
Table 26. Americas Immunocell Therapy Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Immunocell Therapy Market Size Market Share by Application (2020-2025)
Table 28. APAC Immunocell Therapy Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Immunocell Therapy Market Size Market Share by Region (2020-2025)
Table 30. APAC Immunocell Therapy Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Immunocell Therapy Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Immunocell Therapy Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Immunocell Therapy Market Size Market Share by Country (2020-2025)
Table 34. Europe Immunocell Therapy Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Immunocell Therapy Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Immunocell Therapy Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Immunocell Therapy Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Immunocell Therapy Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Immunocell Therapy
Table 40. Key Market Challenges & Risks of Immunocell Therapy
Table 41. Key Industry Trends of Immunocell Therapy
Table 42. Global Immunocell Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Immunocell Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Immunocell Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Immunocell Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Novartis Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 47. Novartis Immunocell Therapy Product Offered
Table 48. Novartis Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Novartis Main Business
Table 50. Novartis Latest Developments
Table 51. Gilead Sciences Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 52. Gilead Sciences Immunocell Therapy Product Offered
Table 53. Gilead Sciences Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Gilead Sciences Main Business
Table 55. Gilead Sciences Latest Developments
Table 56. Bristol-Myers Squibb Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 57. Bristol-Myers Squibb Immunocell Therapy Product Offered
Table 58. Bristol-Myers Squibb Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Bristol-Myers Squibb Main Business
Table 60. Bristol-Myers Squibb Latest Developments
Table 61. J & J Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 62. J & J Immunocell Therapy Product Offered
Table 63. J & J Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. J & J Main Business
Table 65. J & J Latest Developments
Table 66. JW Therapeutics Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 67. JW Therapeutics Immunocell Therapy Product Offered
Table 68. JW Therapeutics Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. JW Therapeutics Main Business
Table 70. JW Therapeutics Latest Developments
Table 71. FOSUNKite Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 72. FOSUNKite Immunocell Therapy Product Offered
Table 73. FOSUNKite Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. FOSUNKite Main Business
Table 75. FOSUNKite Latest Developments
Table 76. CARsgen Therapeutics (Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 77. CARsgen Therapeutics (Pipeline) Immunocell Therapy Product Offered
Table 78. CARsgen Therapeutics (Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. CARsgen Therapeutics (Pipeline) Main Business
Table 80. CARsgen Therapeutics (Pipeline) Latest Developments
Table 81. Autolus Therapeutics(Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 82. Autolus Therapeutics(Pipeline) Immunocell Therapy Product Offered
Table 83. Autolus Therapeutics(Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Autolus Therapeutics(Pipeline) Main Business
Table 85. Autolus Therapeutics(Pipeline) Latest Developments
Table 86. Sorrento Therapeutics(Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 87. Sorrento Therapeutics(Pipeline) Immunocell Therapy Product Offered
Table 88. Sorrento Therapeutics(Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Sorrento Therapeutics(Pipeline) Main Business
Table 90. Sorrento Therapeutics(Pipeline) Latest Developments
Table 91. Mustang Bio(Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 92. Mustang Bio(Pipeline) Immunocell Therapy Product Offered
Table 93. Mustang Bio(Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Mustang Bio(Pipeline) Main Business
Table 95. Mustang Bio(Pipeline) Latest Developments
Table 96. Bluebird Bio(Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 97. Bluebird Bio(Pipeline) Immunocell Therapy Product Offered
Table 98. Bluebird Bio(Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Bluebird Bio(Pipeline) Main Business
Table 100. Bluebird Bio(Pipeline) Latest Developments
Table 101. Cellectis(Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 102. Cellectis(Pipeline) Immunocell Therapy Product Offered
Table 103. Cellectis(Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Cellectis(Pipeline) Main Business
Table 105. Cellectis(Pipeline) Latest Developments
Table 106. Allogene Therapeutics(Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 107. Allogene Therapeutics(Pipeline) Immunocell Therapy Product Offered
Table 108. Allogene Therapeutics(Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. Allogene Therapeutics(Pipeline) Main Business
Table 110. Allogene Therapeutics(Pipeline) Latest Developments
Table 111. Celyad(Pipeline) Details, Company Type, Immunocell Therapy Area Served and Its Competitors
Table 112. Celyad(Pipeline) Immunocell Therapy Product Offered
Table 113. Celyad(Pipeline) Immunocell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Celyad(Pipeline) Main Business
Table 115. Celyad(Pipeline) Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Immunocell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immunocell Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Immunocell Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Immunocell Therapy Sales Market Share by Country/Region (2024)
Figure 8. Immunocell Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Immunocell Therapy Market Size Market Share by Type in 2024
Figure 10. Immunocell Therapy in Hospitals
Figure 11. Global Immunocell Therapy Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Immunocell Therapy in Clinics
Figure 13. Global Immunocell Therapy Market: Clinics (2020-2025) & ($ millions)
Figure 14. Immunocell Therapy in Others
Figure 15. Global Immunocell Therapy Market: Others (2020-2025) & ($ millions)
Figure 16. Global Immunocell Therapy Market Size Market Share by Application in 2024
Figure 17. Global Immunocell Therapy Revenue Market Share by Player in 2024
Figure 18. Global Immunocell Therapy Market Size Market Share by Region (2020-2025)
Figure 19. Americas Immunocell Therapy Market Size 2020-2025 ($ millions)
Figure 20. APAC Immunocell Therapy Market Size 2020-2025 ($ millions)
Figure 21. Europe Immunocell Therapy Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Immunocell Therapy Market Size 2020-2025 ($ millions)
Figure 23. Americas Immunocell Therapy Value Market Share by Country in 2024
Figure 24. United States Immunocell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Immunocell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Immunocell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Immunocell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Immunocell Therapy Market Size Market Share by Region in 2024
Figure 29. APAC Immunocell Therapy Market Size Market Share by Type (2020-2025)
Figure 30. APAC Immunocell Therapy Market Size Market Share by Application (2020-2025)
Figure 31. China Immunocell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Immunocell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Immunocell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Immunocell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 35. India Immunocell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Immunocell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Immunocell Therapy Market Size Market Share by Country in 2024
Figure 38. Europe Immunocell Therapy Market Size Market Share by Type (2020-2025)
Figure 39. Europe Immunocell Therapy Market Size Market Share by Application (2020-2025)
Figure 40. Germany Immunocell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 41. France Immunocell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Immunocell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Immunocell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Immunocell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Immunocell Therapy Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Immunocell Therapy Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Immunocell Therapy Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Immunocell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Immunocell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Immunocell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Immunocell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Immunocell Therapy Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 54. APAC Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 55. Europe Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 57. United States Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 58. Canada Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 59. Mexico Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 60. Brazil Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 61. China Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 62. Japan Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 63. Korea Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 65. India Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 66. Australia Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 67. Germany Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 68. France Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 69. UK Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 70. Italy Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 71. Russia Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 72. Egypt Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 73. South Africa Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 74. Israel Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 75. Turkey Immunocell Therapy Market Size 2026-2031 ($ millions)
Figure 76. Global Immunocell Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Immunocell Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Immunocell Therapy Market Size 2026-2031 ($ millions)